This novel AML-prone mouse model provides a valuable tool for studying leukemogenesis in FA and provides in vivo evidence implicating SAC insufficiency as a driver of tumorigenesis in the setting of FA pathway deficiency. This evidence concerns the gene ADCY10 and acute myeloid leukemia.